Professional
Added to YB: 2024-11-08
Pitch date: 2024-10-18
DXCM [bullish]
DexCom, Inc.
-6.83%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
Market Cap
$23.5B
Pitch Price
$71.87
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.49
P/E
33.52
EV/Sales
5.04
Sector
Health Care Equipment and Supplies
Category
growth
Aristotle Focus Growth Portfolio Holding: DexCom, Inc.
DXCM: Q3 earnings miss due to DME channel share loss, early insurance rebate threshold, and salesforce realignment slowing new patient starts. Management addressing execution issues, maintaining 15%+ long-term growth target. Attractive valuation given strong growth profile.
Read full article (1 min)